Event

In recent years, with the increasing emphasis on scientific and technological innovation in China, the continuous advancement of supporting medical reform policies, and the impact of the pandemic, the living environment of pharmaceutical enterprises and medical device companies has quietly changed. With the rise of technologies such as 5G, Internet of Things, AI, and big data, the ecological operation efficiency of pharmaceutical enterprises has been greatly improved, thereby improving the overall innovation capability of the industry. The digital development has gone through multiple stages, gradually realizing the accumulation, efficiency improvement and exponential growth of the industry. However, at the same time, the enterprises still face internal and external resistance in the process of digital layout. How to further strengthen the construction of digital pharma, improve the level of intelligent manufacturing, and realize the digital transformation of the entire industry chain of pharmaceutical R&D, production, compliance, marketing and circulation, are still their goals.

The “3rd China DigiPharma Innovation Summit” will gather CIOs, IT Directors, and the Head of Manufacturing, Marketing, R&D Department and excellent solutions providers from relevant domestic and foreign well-known pharmaceutical enterprises and medical device companies so as to find the best business partners. The webinar on Dec. 13th will dicuss topics such as the latest cloud-native applications, data governance, remote office and network security. The offline summit on Dec. 15th will discuss digital transformation, digital factories, and digital marketing strategies of pharmaceutical companies under the reform of the pharmaceutical industry.